1.1350
+0.0550
+(5.09%)
As of 3:34:33 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,596.0000
--
69,963.0000
2,573.0000
64,872.0000
Cost of Revenue
--
--
1,397.0000
1,402.0000
15,975.0000
Gross Profit
1,596.0000
--
68,566.0000
1,171.0000
48,897.0000
Operating Expense
6,387.0000
--
57,903.0000
80,748.0000
204,438.0000
Operating Income
-4,791.0000
--
10,663.0000
-79,577.0000
-155,541.0000
Net Non Operating Interest Income Expense
--
--
--
-32,917.0000
-28,581.0000
Other Income Expense
674.0000
--
-9,589.0000
272.0000
598.0000
Pretax Income
-4,010.0000
--
1,074.0000
-79,305.0000
-183,524.0000
Tax Provision
-43.0000
--
--
--
--
Net Income Common Stockholders
-3,316.0000
--
111,997.0000
-172,415.0000
-183,524.0000
Diluted NI Available to Com Stockholders
-3,316.0000
--
111,997.0000
-172,415.0000
-183,524.0000
Basic EPS
-0.27
-0.98
12.41
-21.50
-33.50
Diluted EPS
-0.27
-0.98
11.96
-21.50
-33.50
Basic Average Shares
11,409.2500
10,441.0000
9,028.0000
7,959.8400
5,512.9710
Diluted Average Shares
11,409.2500
10,441.0000
9,366.0000
7,959.8400
5,512.9710
Total Operating Income as Reported
-6,052.0000
--
1,191.0000
-79,577.0000
-155,541.0000
Total Expenses
6,387.0000
--
59,300.0000
82,150.0000
220,413.0000
Net Income from Continuing & Discontinued Operation
-3,316.0000
--
111,997.0000
-172,415.0000
-183,524.0000
Normalized Income
-2,719.5219
--
10,546.0000
-79,305.0000
-183,524.0000
Interest Expense
--
--
--
22,568.0000
26,049.0000
Net Interest Income
--
--
--
-32,917.0000
-28,581.0000
EBIT
-4,898.0000
--
10,663.0000
-79,577.0000
-157,475.0000
EBITDA
-3,852.0000
--
11,863.0000
-78,841.0000
-153,408.0000
Reconciled Cost of Revenue
--
--
1,390.0000
1,402.0000
15,975.0000
Reconciled Depreciation
1,024.0000
--
1,200.0000
736.0000
4,067.0000
Net Income from Continuing Operation Net Minority Interest
-3,967.0000
--
1,074.0000
-79,305.0000
-183,524.0000
Total Unusual Items Excluding Goodwill
-1,261.0000
--
-9,472.0000
--
--
Total Unusual Items
-1,261.0000
--
-9,472.0000
--
--
Normalized EBITDA
-2,591.0000
--
21,335.0000
-78,841.0000
-153,408.0000
Tax Rate for Calcs
0.0000
--
--
--
--
Tax Effect of Unusual Items
-13.5219
--
--
--
--
12/31/2020 - 5/9/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANIK Anika Therapeutics, Inc.
16.39
+0.12%
CPHI China Pharma Holdings, Inc.
0.2008
+10.03%
YCBD cbdMD, Inc.
0.5987
-0.22%
KNSA Kiniksa Pharmaceuticals International, plc
20.06
+1.47%
SXTC China SXT Pharmaceuticals, Inc.
0.4200
+7.39%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.8850
-6.12%
PTLF Petlife Pharmaceuticals, Inc.
0.0001
0.00%
LWA.F ECO Animal Health Group plc
0.7350
0.00%
ER4.SG Emergent BioSolutions Inc
10.74
-1.69%
KHTRF Knight Therapeutics Inc.
3.8800
0.00%